Mankind Pharma has executed the Business Transfer Agreement (BTA) on 03 September 2024 to transfer Over the Counter (OTC) Business Undertaking (defined in the BTA) of the Company as a going concern on a slump sale basis to Mankind Consumer Products (MCPPL), a wholly owned subsidiary of the Company. The completion of slump sale of OTC Business Undertaking to MCPPL is subject to pre-conditions, closing actions and other terms and conditions as specified in the BTA.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "carbon emission, carbon tax, climate change, pollution")
 "GIC")
 "hiring")
 "Gensol, Gensol engineering")
 "raw cane sugar")
